Harmony Biosciences Holdings (HRMY) Other Working Capital Changes (2019 - 2026)
Harmony Biosciences Holdings' (HRMY) quarterly Other Working Capital Changes came in at $3.0 million in Q1 2026, up 49.87% year-on-year from $2.0 million in Q1 2025, and up 112.06% quarter-over-quarter from -$24.8 million in Q4 2025.
Harmony Biosciences Holdings (HRMY) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has disclosed Other Working Capital Changes across 8 years of filings, most recently posting $3.0 million for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $3.0 million, up 49.87% year-over-year; the trailing twelve-month figure through Mar 2026 was -$30.8 million (down 2063.65% YoY), and the FY2025 annual result was -$31.8 million, down 1156.75% from the prior year.
- Other Working Capital Changes came in at $3.0 million for Q1 2026 at Harmony Biosciences Holdings, up from -$24.8 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $7.7 million in Q4 2022 to a low of -$24.8 million in Q4 2025.
- The 5-year median for Other Working Capital Changes is $565000.0 (2024), against an average of -$1.1 million.
- Peak annual rise in Other Working Capital Changes reached 4852.47% in 2022, while the deepest fall reached 7379.25% in 2022.
- Harmony Biosciences Holdings' Other Working Capital Changes stood at $7.7 million in 2022, then tumbled by 123.81% to -$1.8 million in 2023, then decreased by 0.55% to -$1.8 million in 2024, then slumped by 1248.07% to -$24.8 million in 2025, then jumped by 112.06% to $3.0 million in 2026.
- The last three Other Working Capital Changes figures came in at $3.0 million (Q1 2026), -$24.8 million (Q4 2025), and -$12.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | -24.85 Mn |
| Dec 31, 2025 | -24.85 Mn |
| Sep 30, 2025 | -12.53 Mn |
| Sep 30, 2025 | -12.53 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Sep 30, 2024 | 847,000.00 |
| Sep 30, 2024 | 847,000.00 |
| Jun 30, 2024 | 565,000.00 |
| Jun 30, 2024 | 565,000.00 |
| Mar 31, 2024 | 3.44 Mn |
| Mar 31, 2024 | 3.44 Mn |
| Dec 31, 2023 | -1.83 Mn |
| Dec 31, 2023 | -1.83 Mn |